Browse
Submit Data
Databases
API
Help

Dataset Information

24 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Synthesis and Opioid Activity of Tyr1 -?[(Z)CF=CH]-Gly2 and Tyr1 -?[(S)/(R)-CF3 CH-NH]-Gly2 Leu-enkephalin Fluorinated Peptidomimetics.

ABSTRACT: We describe the design, synthesis, and opioid activity of fluoroalkene (Tyr1 -?[(Z)CF=CH]-Gly2 ) and trifluoroethylamine (Tyr1 -?[(S)/(R)-CF3 CH-NH]-Gly2 ) analogues of the endogenous opioid neuropeptide, Leu-enkephalin. The fluoroalkene peptidomimetic exhibited low nanomolar functional activity (5.0±2?nm and 60±15?nm for ?- and ?-opioid receptors, respectively) with a ?/?-selectivity ratio that mimics that of the natural peptide. However, the trifluoroethylamine peptidomimetics, irrespective of stereochemistry, did not activate the opioid receptors, which suggest that bulky CF3 substituents are not tolerated at this position.

SUBMITTER: Karad SN

PROVIDER: S-EPMC5486982 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Synthesis and Opioid Activity of Tyr1 -ψ[(Z)CF=CH]-Gly2 and Tyr1 -ψ[(S)/(R)-CF3 CH-NH]-Gly2 Leu-enkephalin Fluorinated Peptidomimetics.

Karad Somnath Narayan SN Pal Mohan M Crowley Rachel S RS Prisinzano Thomas E TE Altman Ryan A RA

ChemMedChem 20170405 8

We describe the design, synthesis, and opioid activity of fluoroalkene (Tyr1 -ψ[(Z)CF=CH]-Gly2 ) and trifluoroethylamine (Tyr1 -ψ[(S)/(R)-CF3 CH-NH]-Gly2 ) analogues of the endogenous opioid neuropeptide, Leu-enkephalin. The fluoroalkene peptidomimetic exhibited low nanomolar functional activity (5.0±2 nm and 60±15 nm for δ- and μ-opioid receptors, respectively) with a μ/δ-selectivity ratio that mimics that of the natural peptide. However, t ...[more]

PMID: 28296145

Similar Datasets

Solid-Phase Synthesis of Gly-Ψ[CH(CF3)NH]-Peptides.

Project description:The solid-phase synthesis of Gly-Ψ[CH(CF3)NH]-peptides is presented. In order to achieve this goal, the synthesis of Gly-Ψ[CH(CF3)NH]-dipeptides having the C-terminus unprotected, the N-terminus protected as Fmoc- or Teoc-, and possibly side chain functionalities protected with acid-labile protecting groups has been developed. A selected small library of six peptidomimetics, encompassing analogues of biological relevant peptides, have been obtained in high purity.

| S-EPMC8279481 | biostudies-literature

Tyr1-?[( Z)CF?CH]-Gly2 Fluorinated Peptidomimetic Improves Distribution and Metabolism Properties of Leu-Enkephalin.

Project description:Opioid peptides are key regulators in cellular and intercellular physiological responses, and could be therapeutically useful for modulating several pathological conditions. Unfortunately, the use of peptide-based agonists to target centrally located opioid receptors is limited by poor physicochemical (PC), distribution, metabolic, and pharmacokinetic (DMPK) properties that restrict penetration across the blood-brain barrier via passive diffusion. To address these problems, the present paper exploits fluorinated peptidomimetics to simultaneously modify PC and DMPK properties, thus facilitating entry into the central nervous system. As an initial example, the present paper exploited the Tyr1-?[( Z)CF?CH]-Gly2 peptidomimetic to improve PC druglike characteristics (computational), plasma and microsomal degradation, and systemic and CNS distribution of Leu-enkephalin (Tyr-Gly-Gly-Phe-Leu). Thus, the fluoroalkene replacement transformed an instable in vitro tool compound into a stable and centrally distributed in vivo probe. In contrast, the Tyr1-?[CF3CH2-NH]-Gly2 peptidomimetic decreased stability by accelerating proteolysis at the Gly3-Phe4 position.

| S-EPMC6051889 | biostudies-literature

Synthesis of Leu-Enkephalin Peptidomimetics Containing Trifluoromethylalkenes as Amide Isopolar Mimics.

Project description:Fluorinated peptidomimetics are valuable substrates for exploring peptide backbone conformations and for perturbing physicochemical properties of probe compounds. However, in some cases synthetic limitations restrict installation of the fluorinated peptidomimetics into the desired probe compounds. For instance, trifluoromethylalkenes have served as amide isopolar mimics, but are rarely utilized, because many standard peptide-coupling conditions promote the isomerization of the alkene to thermodynamically favored positions. To address this challenge, we report the conversion of a naturally occurring amino acid to a Tyr1-ψ/[CF3C=CH]-Gly2 dipeptide mimetic, and notably, successful peptide coupling reactions that avoid alkene isomerization. Using this strategy, we generated trifluoromethylalkene-containing Leu-enkephalin peptidomimetics in high purity and good yield. This sequence suggests that the trifluoromethylalkene peptidomimetics can be incorporated into other target molecules with appropriate optimization.

| S-EPMC6499489 | biostudies-literature

Ionic Association in CH3-(CH2-CF2) n -CH3(PVDF)-Li+-(CF3SO2)2N- for n = 1, 4: A Computational Approach.

Project description:The ionic conductivity of solid polymer electrolytes is governed by the ionic association caused by the polymer···Li+ and the anion···Li+ interactions. We performed the density functional calculation to analyze the molecular interactions in the CH3-(CH2-CF2) n -CH3-Li+-(CF3SO2)2N- for n = 1,4 systems. The gauche conformation is predicted in the lowest energy conformer of pure polymer except for n = 1. The lithium coordination number with the polymer is changed from 3 to 2 in the presence of anion for n = 2, 4 systems. The consequences of the Li+ ion and Li+-(CF3SO2)2N- to the vibrational spectrum are studied to understand the ionic association at the molecular level.

| S-EPMC8892668 | biostudies-literature

Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2), in mice.

Project description:Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2) (SK-9709) is a dynorphin derivative in which the peptide bond was replaced with a psi (CH(2)NH) bond. In the present study, the antinociceptive effects of SK-9709 were determined in an acetic acid-induced writhing test and a hot-plate test. In the acetic acid-induced writhing test, significant antinociceptive effects were observed after subcutaneous (s.c.), intracerebroventricular (i.c.v.) and intrathecal (i.t.) injection of SK-9709, with maximal effects at 120, 30 and 15 min, respectively. The antinociceptive effects were dose-dependent and ED(50) values (range of 95% confidence limits) after s.c., i.c.v. and i.t. injection were 1.36 (0.61 - 3.02) micromol kg(-1), 2.11 (1.18 - 3.79) and 0.79 (0.61 - 1.03) nmol per mouse, respectively. The effects of SK-9709 (s.c., i.c.v. and i.t.) were reversed by the opioid receptor antagonist naloxone (1.36 micromol kg(-1), s.c.). The effects of SK-9709 (s.c.) were also reversed by the selective mu-opioid receptor antagonist beta-funaltrexamine (4.7 nmol per mouse, i.c.v.), and kappa-opioid receptor antagonist nor-binaltorphimine (4.9 nmol per mouse, i.t.). In the hot-plate test, the antinociceptive effect of SK-9709 (s.c., i.c.v. and i.t.) was also dose-dependent with the maximal peak effect at 120, 15 and 15 min similarly to the acetic acid-induced writhing test. The antinociceptive effects were dose-dependent and ED(50) values (range of 95% confidence limits) after s.c., i.c.v. and i.t. injection were 39.1 (5.4 - 283.0) micromol kg(-1), 6.5 (4.0 - 10.7) and 7.4 (5.0 - 11.0) nmol per mouse, respectively. These findings indicated that systemically administered SK-9709 produced long-lasting antinociceptive effects and these effects were mediated by both supra-spinal mu- and spinal kappa-opioid receptors.

| S-EPMC1572722 | biostudies-other

Product distribution and mechanism of the OH- initiated tropospheric degradation of three CFC replacement candidates: CH3CF[double bond, length as m-dash]CH2, (CF3)2C[double bond, length as m-dash]CH2 and (E/Z)-CF3CF[double bond, length as m-dash]CHF.

Project description:The OH radical initiated photodegradation of 2-fluoropropene (CH3CF[double bond, length as m-dash]CH2), 3,3,3-trifluoro-2-(tri-fluoromethyl)propene ((CF3)2C[double bond, length as m-dash]CH2) and (E/Z)-1,2,3,3,3-pentafluoropropene ((E/Z)-CF3CF[double bond, length as m-dash]CHF) has been investigated for the first time using a 1080 L quartz-glass environmental chamber at 298 ± 2 K and atmospheric pressure of synthetic air coupled with in situ FTIR spectroscopy to monitor reactants and products. The major products observed in the OH reaction were CH3C(O)F (98 ± 5)% together with HC(O)H (89 ± 7)% as a co-product, CF3C(O)F (103 ± 8)% together with HC(O)F (96 ± 7)% as a co-product and CF3C(O)CF3 (91 ± 8)% together with HC(O)H (98 ± 12)% as a co-product from the C1-C2 bond cleavage channel of the intermediate hydroxyalkoxy radical, formed by addition of OH to the terminal carbon of the double bond which is designated C1 of 2-fluoropropene, (E/Z)-1,2,3,3,3-pentafluoropropene and 3,3,3-trifluoro-2-(tri-fluoromethyl)propene, respectively. The present results are compared with previous studies for the reaction of OH with the separate isomers (E) and (Z) of 1,2,3,3,3-pentafluoropropene. In addition, atmospheric implications of the reactions studied are discussed.

| S-EPMC9060772 | biostudies-literature

Trifluoromethyl Thianthrenium Triflate: A Readily Available Trifluoromethylating Reagent with Formal CF3+, CF3•, and CF3- Reactivity.

Project description:Here we report the synthesis and application of trifluoromethyl thianthrenium triflate (TT-CF3+OTf-) as a novel trifluoromethylating reagent, which is conveniently accessible in a single step from thianthrene and triflic anhydride. We demonstrate the use of TT-CF3+OTf- in electrophilic, radical, and nucleophilic trifluoromethylation reactions.

| S-EPMC8297735 | biostudies-literature

Allosteric modulation of the dopamine receptor by conformationally constrained type VI beta-turn peptidomimetics of Pro-Leu-Gly-NH2.

Project description:A peptidomimetic of Pro-Leu-Pro-NH2, 7, possessing an indolizidinone type VI beta-turn mimic was synthesized via improved high-yielding protocols for the preparation and Cbz protection of alpha-allylproline. Bicyclic peptidomimetic 7 and spirobicylic peptidomimetic 8 enhanced the binding of [3H] N-propylnorapomorphine to dopamine receptors indicating that a type VI beta-turn is a possible bioactive conformation of the homochiral Pro-Leu-Pro-NH2 and Pro-Pro-Pro-NH 2 analogues of Pro-Leu-Gly-NH2 at the dopamine receptor allosteric regulatory site.

| S-EPMC2529021 | biostudies-literature

A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.

Project description:The hepatitis C virus (HCV) glycoproteins E1 and E2 form a heterodimer that mediates CD81 receptor binding and viral entry. In this study, we used site-directed mutagenesis to examine the functional role of a conserved G436WLAGLFY motif of E2. The mutants could be placed into two groups based on the ability of mature virion-incorporated E1E2 to bind the large extracellular loop (LEL) of CD81 versus the ability to mediate cellular entry of pseudotyped retroviral particles. Group 1 comprised E2 mutants where LEL binding ability largely correlated with viral entry ability, with conservative and nonconservative substitutions (W437 L/A, L438A, L441V/F, and F442A) inhibiting both functions. These data suggest that Trp-437, Leu-438, Leu-441, and Phe-442 directly interact with the LEL. Group 2 comprised E2 glycoproteins with more conservative substitutions that lacked LEL binding but retained between 20% and 60% of wild-type viral entry competence. The viral entry competence displayed by group 2 mutants was explained by residual binding by the E2 receptor binding domain to cellular full-length CD81. A subset of mutants maintained LEL binding ability in the context of intracellular E1E2 forms, but this function was largely lost in virion-incorporated glycoproteins. These data suggest that the CD81 binding site undergoes a conformational transition during glycoprotein maturation through the secretory pathway. The G436P mutant was an outlier, retaining near-wild-type levels of CD81 binding but lacking significant viral entry ability. These findings indicate that the G436WLAGLFY motif of E2 functions in CD81 binding and in pre- or post-CD81-dependent stages of viral entry.

| S-EPMC1563787 | biostudies-literature

Unsaturated Vinyl-Type Carbocation [(CH3)2C=CH]+ in Its Carborane Salts.

Project description:The isobutylene carbocation (CH3)2C=CH+ was obtained in amorphous and crystalline salts with the carborane anion CHB11Cl11 -. The cation was characterized by X-ray crystallography and IR spectroscopy. Its crystal structure shows a relatively uniform ionic interaction of the cation with the surrounding anions, with a slightly shortened distance between the C atom of the =CH group and the Cl atom of the anion, pointing to a higher positive charge on this group. In the amorphous phase, the asymmetric interaction of the cation with the anion increases, approaching ion pairing. This gives rise to a strong hyperconjugation between the two CH3 groups and the 2pz orbital of the central carbon sp2 atom (the red shift of the CH stretch is 150 cm-1); this effect stabilizes the cation. Over time, as the structure of the amorphous phase becomes more ordered, the hyperconjugation weakens and disappears in the crystalline phase with the disappearance of ion pairing. The carbocation stabilization in the crystalline phase is achieved due to the transfer of a portion of the charge to the neighboring anions, whereas the charge on the C=C bond becomes the strongest: the C=C stretch frequency drops to ∼160 cm-1 relative to neutral isobutylene. The collected IR spectra for the optimized cation under vacuum (in the 6-311G ++ (d, p) basis for all HF, MP2, and DFT calculations) predict that a positive charge on the C=C bond increases its stretching frequency; this computational result contradicts the experimental data, perhaps because it does not take into account the significant impact of the environment.

| S-EPMC8223440 | biostudies-literature